Effect of nebivolol and metoprolol treatments on serum asymmetric dimethlyarginine levels in hypertensive patients with type 2 diabetes mellitus

dc.contributor.authorMenevse, Esma
dc.date.accessioned2020-03-26T17:26:42Z
dc.date.available2020-03-26T17:26:42Z
dc.date.issued2008
dc.departmentSelçuk Üniversitesien_US
dc.description.abstract[Abstract not Available]en_US
dc.identifier.endpage84en_US
dc.identifier.issn2149-2263en_US
dc.identifier.issn2149-2271en_US
dc.identifier.issue1en_US
dc.identifier.pmid18258550en_US
dc.identifier.scopusqualityQ3en_US
dc.identifier.startpage84en_US
dc.identifier.urihttps://hdl.handle.net/20.500.12395/22341
dc.identifier.volume8en_US
dc.identifier.wosWOS:000254244400031en_US
dc.identifier.wosqualityN/Aen_US
dc.indekslendigikaynakWeb of Scienceen_US
dc.indekslendigikaynakScopusen_US
dc.indekslendigikaynakTR-Dizinen_US
dc.indekslendigikaynakPubMeden_US
dc.language.isoenen_US
dc.publisherTURKISH SOC CARDIOLOGYen_US
dc.relation.ispartofANATOLIAN JOURNAL OF CARDIOLOGYen_US
dc.relation.publicationcategoryDiğeren_US
dc.rightsinfo:eu-repo/semantics/openAccessen_US
dc.selcuk20240510_oaigen_US
dc.titleEffect of nebivolol and metoprolol treatments on serum asymmetric dimethlyarginine levels in hypertensive patients with type 2 diabetes mellitusen_US
dc.typeLetteren_US

Dosyalar